Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Advances in identification and application of tumor antigen inducing anti-cancer responses

  • 14 Accesses

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Wang, R. F., Tumor antigens discovery: perspectives for cancer therapy, Mol. Med., 1997, 3(11): 716–731.

  2. 2.

    Rosenberg, S. A., A new era for cancer immunotherapy based on the genes that encode cancer antigens, Immunity, 1999, 10: 281–287.

  3. 3.

    Boon, T., Coulie, P. G., Van den, E. B., Tumor antigens recognized by T cells, Immunol., 1997, 18: 267–268.

  4. 4.

    Van der Bruggen, P., Traversari, C., Chomez, P. et al., A gene encoding an antigen-recognized by cytolytic T lymphocytes on a human melanoma, Science, 1991, 254: 1643–1647.

  5. 5.

    Wang, F., Pang, X. W., Chen, W. F. et al., Large scale identification of human hepatocellular carcinoma-associated antigens by autoantibodies, J. Immunol., 2002, 169: 1102–1109.

  6. 6.

    Panelli, M. C., Bettinotti, M. P., Lally, K. et al., A tumorinfiltrating lymphocyte from a melanoma metastasis with decreased expression of melanoma differentiation antigens recognizes MAGE-12, J. Immunol., 2000, 4382–4392.

  7. 7.

    Wang, R. F., Wang, X., Rosenberg, S. A. et al., Cloning genes encoding MHC class II-restricted antigens: mutated CDC27 as a tumor antigen, Science, 1999, 284: 1351–1354.

  8. 8.

    Boel, P., Wildmann, C., Sensi, M. L. et al., BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes, Immunity, 1995, 2: 167–175.

  9. 9.

    Jager, E., Chen, Y. T., Drijfhout, J. W., Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes, J. Exp. Med., 1998, 187: 265–270.

  10. 10.

    Wang, R. F., Johnston, S. L., Zeng, G. et al., A breast and melanoma-shared tumor antigenic peptides translated from different open reading frames, J. Immunol., 1998, 161: 3596–3606.

  11. 11.

    Chiari, R., Foury, F., Plaen, E. D. et al., Two antigens recogized by autologous cytolytic T lymphocytes on a melanoma result from a single point mutation in an essential housekeeping gene, Cancer Res., 1999, 22: 5785–5792.

  12. 12.

    Mandruzzato, S., Brasseur, F., Andry, G. A., CASP-8 mutation recognized by cytolytic T lymphocytes on a human head and neck carcinoma, J. Exp. Med., 1997, 186: 785–793.

  13. 13.

    Gueguen, M., Matard, J., Gaugier, B., An antigen recognized by autologous CTLs on a human bladder carcinoma, J. Immunol., 1998, 160: 6188–6194.

  14. 14.

    Vissers, J. L., De, Vries. I. J., Schreurs, M. W. et al., The renal cell carcinoma-associated antigen G250 encodes a human leukocyte antigen (HLA)-A2.1-restricted epitope recognized by cytotoxic T lymphocytes, Cancer Res., 1999, 59: 5554–5559.

  15. 15.

    Theobald, M. B., Dittmer, D., Sherman, L. A. et al., Targeting p53 as a general tumor antigen, Proc. Natl. Acad. Sci. USA, 1995, 92: 11993–11997.

  16. 16.

    Wang, R. F., Wang, X., Rosenberg, S. A., Identification of a novel major histocompatibility complex class II-restricted tumor antigen resulting from a chromosomal rearrangement recognized by CD4+ T cells, J. Exp. Med., 1999, 189: 1659–1667.

  17. 17.

    Wei, Y. Q., Huang, M. J., Yang, L. et al., Immunogene Therapy of Tumors with Vaccine Based on Xenopus Homologous Vascular Endothelial Growth Factoras a Model Antigen, Proc. Natl. Acad. Sci. USA, 2001, 98(20): 11545–11550.

  18. 18.

    Wei, Y. Q., Immunotherapy of tumors with vaccine based on xenogeneic molecules, Anti-cancer Drugs, 2002, 13(3): 229–235.

  19. 19.

    Wei, Y. Q., Wang, Q. R., Zhao, X. et al., Immunotherapy of tumors with Xenogeneic endothelial cells as a vaccine, Nat. Med., 2000, 6: 1160–1166.

  20. 20.

    Sahin, U., Tureci, O., Schmitt, H. et al., Human neoplasms elicit multiple specific immune responses in the autologous host, Proc. Natl. Acad. Sci. USA, 1995, 95(25): 11810–11813.

  21. 21.

    Old, L. J., Chen, Y. T., New paths in human cancer serology, J. Exp. Med., 1998, 187(8): 1163–1167.

  22. 22.

    Chen, Y. T., Scanlan, M. J., Sahin, U. et al., A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening, Proc. Natl. Acad. Sci. USA, 1997, 94(5): 1914–1918.

  23. 23.

    Chen, Y. T., Gure, A. O., Tsang, S. et al., Identification of multiple cancer/testis antigens by allogeneic antibody screening of a melanoma cell line library, Immunology, 1998, 95(12): 6919–6923.

  24. 24.

    Smith, G. P., Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface, Science, 1985, 228: 1315–1317.

  25. 25.

    Scott, J. K., Smith, G. P., Searching for peptide ligands with an epitope library, Science, 1990, 249: 386–390.

  26. 26.

    Nie, Y. Z., He, F. T., Li, Z. K. et al., Identification of tumor associated single-chain Fv by panning and screening antibody phage library using tumor cells, World J. Gastroenterol., 2002, 8(4): 619–623.

  27. 27.

    Hansen, M. H., Ostenstad, B., Sioud, M., Identification of immunogenic antigens using a phage-displayed cDNA library from an invasive ductal breast carcinoma tumour, Int. J. Oncol., 2001, 19(6): 1303–1309.

  28. 28.

    Sioud, M., Hansen, M. H., Profiling the immune response in patients with breast cancer by phage-displayed cDNA libraries, Eur. J. Immunol., 2001, 31(3): 716–725.

  29. 29.

    Hanes, J., Jermutus, L., Schaffitzel, C. et al., Comparison ofEscherichia coli and rabbit reticulocyte ribosome display systems, FEBS Lett., 1999, 450: 105–110.

  30. 30.

    Zhang, H. T., Kacharmina, J. E. Miyashiro, K. et al., Protein quantification from complex protein using a proteomics methodology with single-cell resolution, Proc. Natl. Acad. Sci. USA, 2001, 98(10): 5497–5502.

  31. 31.

    Matthews, L. J., Davis, R., Smith, G. P. et al., Immunogenically fit subunit vaccine components via epitope discovery from nutural peptide libraries, J. Immunol., 2002, 169(2): 837–846.

  32. 32.

    Xu, L., Qiao, T., Chen, B., Mimic epitope recognized by monoclonal antibody MG7 against gastric cancer through screening phage displayed random peptide library, Zhonghua Yi Xue Za Zhi, 2000, 51(2): 79–90.

  33. 33.

    Gulley, J., Chen, A. P., Dahut, W. et al., Phase I study of a vaccine using recombinant vaccinia virus expressing PSA (rV-PSA) in patients with metastatic androgen-independent prostate cancer, Prostate, 2002, 5(2): 109–117.

  34. 34.

    Rosenberg, S. A., Progross in human tumour immunology and immunotherapy, Nature, 2001, 411(6835): 380–384.

  35. 35.

    Borrello, I. M., Sotomayor, E. M., Cancer vaccines for hematologie malignancies, Cancer Control, 2002, 9(2): 138–151.

  36. 36.

    Marahall, J. L., Hawkins, M. J., Tsang, K. Y. et al., Phase I study in cancer patients of a replication-defective avipox recombinant vaccine that expresses human carcinoembryonic antigen, J. Clin. Oncol., 1999, 17(1): 332–337.

  37. 37.

    Fong, L., Hou, Y., Rivas, A. et al., Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy, Proc. Natl. Acad. Sci. USA, 2001, 98(15): 8809–8814.

  38. 38.

    Fong, L., Brockstedt, D., Benike, C. et al., Dendritic cell-based xenoantigen vaccination for prostate cancer immunotherapy, J. Immunol., 2001, 167: 7150–7156.

  39. 39.

    Martin, J., Stribbling, S. M., Poon, G. K. et al., Antibody-directed enzyme produry therapy: pharmacokinetics and plasma levels of prodrug and drug in a phase I clinical trial, Cancer Chemother Pharacol., 1997, 40(3): 189–201.

  40. 40.

    Feng, Z. H., Huang, B., Zhang, G. M. et al., Investigation on the effect of peptides mixture from tumor cells inducing anti-tumor specific immune response, Science in China, Series C, 2002, 32(4): 361–369.

Download references

Author information

Correspondence to Yuquan Wei.

About this article

Cite this article

Xie, K., Tian, L., Deng, H. et al. Advances in identification and application of tumor antigen inducing anti-cancer responses. Chin.Sci.Bull. 48, 1051–1054 (2003). https://doi.org/10.1007/BF03185752

Download citation

Keywords

  • Melanoma
  • Tumor Antigen
  • Kidney Cancer
  • Cancer Vaccine
  • Peptide Library